Microencapsulated Pomegranate Juice as Anti-Hypertensive

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

May 1, 2025

Conditions
Clinical Trial
Interventions
OTHER

Placebo

150 mL of water during the breakfast

DRUG

Positive control

Normal antihypertensive in 150 ml of water during the breakfast

DIETARY_SUPPLEMENT

Active comparator

20 g microencapsulated pomegranate juice in 150 mL water

DIETARY_SUPPLEMENT

Control

150 mL fresh pomegranate juice

Trial Locations (1)

42082

Gabriel Betanzos-Cabrera, Pachuca

All Listed Sponsors
collaborator

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

collaborator

Universidad Nacional Autonoma de Mexico

OTHER

lead

Universidad Autónoma del Estado de Hidalgo

OTHER

NCT07017296 - Microencapsulated Pomegranate Juice as Anti-Hypertensive | Biotech Hunter | Biotech Hunter